SynthesisThe Cochrane database of systematic reviews2013
Progestin-only contraceptives: effects on weight.
Synthesis in The Cochrane database of systematic reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 68 citations in OpenAlex.
- Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2018Pooled it
- Hormonal contraceptives for contraception in overweight or obese women.The Cochrane database of systematic reviews · 2016Pooled it
- Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.The Cochrane database of systematic reviews · 2014Pooled it
- Association of Progestin Contraceptive Implant and Weight Gain.Obstetrics and gynecology · 2016Trial
- 5As Team obesity intervention in primary care: development and evaluation of shared decision-making weight management tools.Clinical obesity · 2015Trial
- Anti-oxidative enzymes, cardiovascular disease risk factors, and adipokines in Nigerian women on oral and implant contraceptives.African health sciences · 2025Article
- Sex as an independent variable in the measurement of satiation: a retrospective cohort study.International journal of obesity (2005) · 2022Article
- The novel BRDT inhibitor NHWD870 shows potential as a male contraceptive in mice.Acta biochimica et biophysica Sinica · 2022Article
- Obesity and hormonal contraception: an overview and a clinician's practical guide.Eating and weight disorders : EWD · 2020Review
- Education and prevalence of overweight and obesity among reproductive age group women in Ethiopia: analysis of the 2016 Ethiopian demographic and health survey data.BMC public health · 2020Article
- Depo-medroxyprogesterone acetate, weight gain and amenorrhea among obese adolescent and adult women.The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception · 2020Article
- Current Issues and Options for Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease: An Update for Health Care Professionals.Mediterranean journal of hematology and infectious diseases · 2020Review
- Changes in body weight and blood pressure among women using Depo-Provera injection in Northwest Ethiopia.BMC research notes · 2019Article
- Assessing Weight Status in Adolescent and Young Adult Users of the Etonogestrel Contraceptive Implant.Journal of pediatric and adolescent gynecology · 2019Article
- Prevalence and factors associated with underweight, overweight and obesity among women of reproductive age in India.Global health research and policy · 2019Article
- Long-Acting Reversible Contraception.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2017Review
- Ovarian hormones and obesity.Human reproduction update · 2017Review
- Changes in body composition in women using long-acting reversible contraception.Contraception · 2017Article
- Incidence of Discontinuation of Long-Acting Reversible Contraception among Adolescent and Young Adult Women Served by an Urban Primary Care Clinic.Journal of pediatric and adolescent gynecology · 2017Article
- Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits.Open access journal of contraception · 2017Review
Corrections and comments
- Updated by
- Update of
Authors and funding
6 authors at 4 institutions in 2 countries.
Funding
Abstract
backgroundProgestin-only contraceptives (POCs) are appropriate for many women who cannot or should not take estrogen. Many POCs are long-acting, cost-effective methods of preventing pregnancy. However, concern about weight gain can deter the initiation of contraceptives and cause early discontinuation among users.
objectivesThe primary objective was to evaluate the association between progestin-only contraceptive use and changes in body weight. SEARCH
methodsThrough May 2013, we searched MEDLINE, CENTRAL, POPLINE, LILACS, ClinicalTrials.gov, and ICTRP. The 2010 search also included EMBASE. For the initial review, we contacted investigators to identify other trials. SELECTION CRITERIA: All comparative studies were eligible that examined a POC versus another contraceptive method or no contraceptive. The primary outcome was mean change in body weight or mean change in body composition. We also considered the dichotomous outcome of loss or gain of a specified amount of weight. DATA COLLECTION AND ANALYSIS: Two authors extracted the data. We computed the mean difference (MD) with 95% confidence interval (CI) for continuous variables. For dichotomous outcomes, the Mantel-Haenszel odds ratio (OR) with 95% CI was calculated. MAIN
resultsWe found 16 studies; one examined progestin-only pills, one studied the levonorgestrel-releasing intrauterine system (LNG-IUS), four examined an implant, and 10 focused on depot medroxyprogesterone acetate (DMPA). Outcomes examined were changes in body weight only (14 studies), changes in both body weight and body composition (1 study), and changes in body composition only (1 study). We did not conduct meta-analysis due to the various contraceptive methods and weight change measures.Comparison groups did not differ significantly for weight change in 12 studies. However, three studies showed weight change differences for POC users compared to women not using a hormonal method. In one study, weight gain (kg) was greater for the DMPA group than the group using a non-hormonal IUD in years one through three [(MD 2.28; 95% CI 1.79 to 2.77), (MD 2.71, 95% CI 2.12 to 3.30), and (MD 3.17; 95% CI 2.51 to 3.83), respectively]. The differences were notable within the normal weight and overweight subgroups. Two implant studies also showed differences in weight change. The implant group (six-capsule) had greater weight gain (kg) compared to the group using a non-hormonal IUD in both studies [(MD 0.47 (95% CI 0.29 to 0.65); (MD 1.10; 95% CI 0.36 to 1.84)]. In one of those studies, the implant group also had greater weight gain than a group using a barrier method or no contraceptive (MD 0.74; 95% CI 0.52 to 0.96).The two studies that assessed body composition change showed differences between POC users and women not using a hormonal method. Adolescents using DMPA had a greater increase in body fat (%) compared to a group not using a hormonal method (MD 11.00; 95% CI 2.64 to 19.36). The DMPA group also had a greater decrease in lean body mass (%) (MD -4.00; 95% CI -6.93 to -1.07). The other study reported differences between an LNG-IUS group and a non-hormonal IUD group in percent change in body fat mass (2.5% versus -1.3%, respectively; reported P value = 0.029) and percent change in lean body mass (-1.4% versus 1.0%, respectively; reported P value = 0.027). AUTHORS'
conclusionsThe overall quality of evidence was moderate to low, given that the studies were evenly divided across the evidence quality groups (high, moderate, low, or very low quality). We found limited evidence of weight gain when using POCs. Mean gain was less than 2 kg for most studies up to 12 months. Weight change for the POC group generally did not differ significantly from that of the comparison group using another contraceptive. Two studies that assessed body composition showed that POC users had greater increases in body fat and decreases in lean body mass compared to users of non-hormonal methods. Appropriate counseling about typical weight gain may help reduce discontinuation of contraceptives due to perceptions of weight gain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.